INVITRO SUSCEPTIBILITIES OF BORRELIA-BURGDORFERI TO 5 ORAL CEPHALOSPORINS AND CEFTRIAXONE

被引:38
作者
AGGER, WA
CALLISTER, SM
JOBE, DA
机构
[1] GUNDERSON CLIN LTD, INFECT DIS SECT, LA CROSSE, WI 54601 USA
[2] UNIV WISCONSIN, DEPT BACTERIOL, MADISON, WI 53706 USA
关键词
D O I
10.1128/AAC.36.8.1788
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We determined the in vitro susceptibilities of eight Borrelia burgdorferi isolates to five oral cephalosporins. MICs for B. burgdorferi 297 were 23-mu-g/ml (cephalexin), 45-mu-g/ml (cefadroxil), 91-mu-g/ml (cefaclor), 0.13-mu-g/ml (cefuroxime), 0.8-mu-g/ml (cefixime), and 0.02-mu-g/ml (ceftriaxone). When B. burgdorferi isolates were exposed to concentrations twice the MIC of cefuroxime, cefixime, or ceftriaxone, at least 72 h of incubation was required to kill 99% of the organisms.
引用
收藏
页码:1788 / 1790
页数:3
相关论文
共 25 条
[21]   TREATMENT OF THE EARLY MANIFESTATIONS OF LYME-DISEASE [J].
STEERE, AC ;
HUTCHINSON, GJ ;
RAHN, DW ;
SIGAL, LH ;
CRAFT, JE ;
DESANNA, ET ;
MALAWISTA, SE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :22-26
[22]   THE SPIROCHETAL ETIOLOGY OF LYME-DISEASE [J].
STEERE, AC ;
GRODZICKI, RL ;
KORNBLATT, AN ;
CRAFT, JE ;
BARBOUR, AG ;
BURGDORFER, W ;
SCHMID, GP ;
JOHNSON, E ;
MALAWISTA, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (13) :733-740
[23]   ANTIBIOTIC-THERAPY OF EARLY EUROPEAN LYME BORRELIOSIS AND ACRODERMATITIS CHRONICA ATROPHICANS [J].
WEBER, K ;
PREACMURSIC, V ;
NEUBERT, U ;
THURMAYR, R ;
HERZER, P ;
WILSKE, B ;
SCHIERZ, G ;
MARGET, W .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 539 :324-345
[24]  
1990, M7A2 NAT COMM CLIN L
[25]  
1988, MORBID ORTAL WEEKLY, V37, P1